ReviewTrends Mol Med2023
Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer.
- Journal
- Trends Mol Med
- Published
- 17 August 2023
- Citations
- 9
- Type
- Review
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 6
- Builds on itStereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma NCT04331041↗
- Builds on itStudy of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Re… NCT03727880↗
- Builds on itPhase I Trial of Defactinib and VS-6766. NCT03875820↗
- Builds on itStudy of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) NCT02758587↗
- Builds on itDefactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer NCT02546531↗
- Builds on itA Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer NCT01335269↗